the cellular pharmacology of doxorubicin resistance ( doxr ) has most commonly been associated with decreased drug uptake , enhanced drug efflux , cross-resistance to multiple anticancer agents , and the overproduction of a mr 170,000 cell surface glycoprotein ( termed p-glycoprotein ) .
C0025248
cell surface glycoprotein
C0017968
glycoprotein